HUP0201738A3 - Use of pyridazine derivatives for producing pharmaceutical compositions for the treatment of tissue damage resulting from ischemia - Google Patents

Use of pyridazine derivatives for producing pharmaceutical compositions for the treatment of tissue damage resulting from ischemia

Info

Publication number
HUP0201738A3
HUP0201738A3 HU0201738A HUP0201738A HUP0201738A3 HU P0201738 A3 HUP0201738 A3 HU P0201738A3 HU 0201738 A HU0201738 A HU 0201738A HU P0201738 A HUP0201738 A HU P0201738A HU P0201738 A3 HUP0201738 A3 HU P0201738A3
Authority
HU
Hungary
Prior art keywords
ischemia
treatment
pharmaceutical compositions
tissue damage
damage resulting
Prior art date
Application number
HU0201738A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HU0201738D0 publication Critical patent/HU0201738D0/hu
Publication of HUP0201738A2 publication Critical patent/HUP0201738A2/hu
Publication of HUP0201738A3 publication Critical patent/HUP0201738A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
HU0201738A 2001-05-24 2002-05-23 Use of pyridazine derivatives for producing pharmaceutical compositions for the treatment of tissue damage resulting from ischemia HUP0201738A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29339301P 2001-05-24 2001-05-24

Publications (3)

Publication Number Publication Date
HU0201738D0 HU0201738D0 (hu) 2002-07-29
HUP0201738A2 HUP0201738A2 (hu) 2003-02-28
HUP0201738A3 true HUP0201738A3 (en) 2003-11-28

Family

ID=23128899

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0201738A HUP0201738A3 (en) 2001-05-24 2002-05-23 Use of pyridazine derivatives for producing pharmaceutical compositions for the treatment of tissue damage resulting from ischemia

Country Status (15)

Country Link
US (1) US6872722B2 (hu)
EP (1) EP1260224B1 (hu)
JP (1) JP2002370984A (hu)
KR (1) KR20020090321A (hu)
CN (1) CN1390547A (hu)
AT (1) ATE289510T1 (hu)
AU (1) AU761191B2 (hu)
CA (1) CA2387007A1 (hu)
CZ (1) CZ20021782A3 (hu)
DE (1) DE60203026T2 (hu)
ES (1) ES2236447T3 (hu)
HU (1) HUP0201738A3 (hu)
PL (1) PL354128A1 (hu)
SK (1) SK7332002A3 (hu)
ZA (1) ZA200203985B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2240657T3 (es) * 2001-02-28 2005-10-16 Pfizer Products Inc. Compuestos de sulfonilpiridazinona utiles como inhibidores de aldosa reductasa.
PL1961420T3 (pl) * 2005-12-16 2012-12-31 Sanwa Kagaku Kenkyusho Co Środek do zapobiegania i leczenia ostrej niewydolności nerek
JPWO2007097301A1 (ja) * 2006-02-20 2009-07-16 株式会社三和化学研究所 脳卒中における脳虚血又は脳虚血再灌流障害の予防又は治療剤
US20240033263A1 (en) 2021-03-18 2024-02-01 Banavara MYLARI Combination of aldose reductase inhibitors and probenecid for the treatment of diabetic complications

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47592B1 (en) 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
US4939140A (en) 1985-11-07 1990-07-03 Pfizer Inc. Heterocyclic oxophthalazinyl acetic acids
JPH01258671A (ja) * 1987-12-01 1989-10-16 Morishita Pharmaceut Co Ltd ５−（１ｈ−イミダゾール−１−イル）−３（２ｈ）−ピリダジノン誘導体
US4996204A (en) 1989-05-11 1991-02-26 Pfizer Inc. Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors
DE9290035U1 (de) * 1991-03-28 1993-11-18 Pfizer Pyridazinonessigsäuren
US5834466A (en) 1994-12-22 1998-11-10 The Regents Of The University Of California Method for protecting of heart by limiting metabolic and ionic abnormalities developed during ischemia, following ischemia or resulting from ischemia
US5506228A (en) * 1995-02-23 1996-04-09 Merck & Co., Inc. 2,6-diaryl pyridazinones with immunosuppressant activity
US5670504A (en) * 1995-02-23 1997-09-23 Merck & Co. Inc. 2,6-diaryl pyridazinones with immunosuppressant activity
DE69840755D1 (de) * 1997-11-19 2009-05-28 Kowa Co Pyridazinderivate und diese als aktiven bestandteil enthaltende medikamente
TWI241295B (en) * 1998-03-02 2005-10-11 Kowa Co Pyridazine derivative and medicine containing the same as effect component
JP2000247959A (ja) * 1999-02-26 2000-09-12 Kowa Co ピリダジン−３−オン誘導体及びこれを含有する医薬
ES2240657T3 (es) * 2001-02-28 2005-10-16 Pfizer Products Inc. Compuestos de sulfonilpiridazinona utiles como inhibidores de aldosa reductasa.
DK1491540T3 (da) * 2001-03-30 2007-03-26 Pfizer Prod Inc Intermediater, der er anvendelige til syntese af pyridazinon-aldosereduktase inhibitorer

Also Published As

Publication number Publication date
DE60203026D1 (de) 2005-03-31
CZ20021782A3 (cs) 2003-03-12
ATE289510T1 (de) 2005-03-15
CN1390547A (zh) 2003-01-15
HU0201738D0 (hu) 2002-07-29
EP1260224B1 (en) 2005-02-23
US20030008871A1 (en) 2003-01-09
DE60203026T2 (de) 2006-05-04
CA2387007A1 (en) 2002-11-24
EP1260224A1 (en) 2002-11-27
US6872722B2 (en) 2005-03-29
JP2002370984A (ja) 2002-12-24
AU4068502A (en) 2002-11-28
ZA200203985B (en) 2003-11-20
HUP0201738A2 (hu) 2003-02-28
ES2236447T3 (es) 2005-07-16
KR20020090321A (ko) 2002-12-02
SK7332002A3 (en) 2003-05-02
AU761191B2 (en) 2003-05-29
PL354128A1 (en) 2002-12-02

Similar Documents

Publication Publication Date Title
IL196301A0 (en) Medicament for the treatment of hapatitis c
HUP0401514A3 (en) Pharmaceutical compositions for the treatment of asthma
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
IL160884A0 (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
IL150742A0 (en) Pyridopyrimidinone derivatives for the treatment of neurodegenerative disease
HUP0400314A3 (en) Pharmaceutical combinations for the treatment of cancer
IL161070A0 (en) Compositions for the treatment of infectious diseases
IL164896A (en) Pharmaceutical compositions comprising immunoconjugates for the treatment of tumors
SI1354597T1 (sl) Farmacevtska kombinacija za zdravljenje tkivne poskodbe zaradi arterijskega irigacijskega defekta
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU2002248319A1 (en) Pharmaceutical composition for the prevention and treatment of scar tissue
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
AU2002315131A1 (en) Aminediols as agents for the treatment of alzheimer's disease
HUP0401427A3 (en) Oral compositions for the treatment of scalp disorders
HUP0104963A3 (en) Compositions for the treatment of skin diseases
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU2002350832A1 (en) Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension
HUP0201738A3 (en) Use of pyridazine derivatives for producing pharmaceutical compositions for the treatment of tissue damage resulting from ischemia
IL160852A0 (en) Pharmaceutical compositions for the treatment of urinary disorders
HUP0400925A3 (en) Azolycarbynol derivatives of aryl (or heteroaryl) for producing pharmaceutical compositions for the treatment of respiratory diseases
AU2003270202A8 (en) Pharmaceutical compositions useful for the treatment of cancers
AU2900100A (en) Methods for inhibiting cathepsin k activity for the treatment of diseases related to bone loss
AU1022501A (en) Use of compositions for the caring treatment of the skin
AU2683500A (en) Compositions for the treatment of pain

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees